siRNA nanohydrogel to fight ovarian cancer

*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************

siRNA nanohydrogel to fight ovarian cancer

Researcher Roman Mezencev holds a sample of nanohydrogel developed for targeted delivery of siRNA to cancer cells and successfully tested in vivo in mice in John McDonald's Georgia Tech lab. Credit: Georgia Tech / Micah Eavenson / Adam Karcz

Additional Information

Groups

College of Sciences, Parker H. Petit Institute for Bioengineering and Bioscience (IBB), Research Horizons, School of Biological Sciences

Categories
Research, Biotechnology, Health, Bioengineering, Genetics, Cancer Research, Life Sciences and Biology
Keywords
siRNA, RNA, cancer, ovarian cancer, John McDonald, nanohydrogel
Status
  • Created By: Ben Brumfield
  • Workflow Status: Published
  • Created On: Nov 7, 2016 - 9:07am
  • Last Updated: Nov 7, 2016 - 9:34am